Jazz Pharmaceuticals Files 8-K Report
Ticker: JAZZ · Form: 8-K · Filed: Nov 21, 2024 · CIK: 1232524
| Field | Detail |
|---|---|
| Company | Jazz Pharmaceuticals PLC (JAZZ) |
| Form Type | 8-K |
| Filed Date | Nov 21, 2024 |
| Risk Level | low |
| Pages | 2 |
| Reading Time | 2 min |
| Key Dollar Amounts | $0.0001 |
| Sentiment | neutral |
Sentiment: neutral
Topics: 8-K, financial-statements, exhibits
Related Tickers: JAZZ
TL;DR
Jazz Pharma filed a routine 8-K, mostly financial exhibits. Nothing major to see here.
AI Summary
On November 20, 2024, Jazz Pharmaceuticals plc filed an 8-K report. The filing primarily concerns financial statements and exhibits, indicating a routine update or disclosure rather than a major event. No specific financial figures or new business developments were detailed in the provided excerpt.
Why It Matters
This filing serves as a public record of Jazz Pharmaceuticals' disclosures to the SEC, providing transparency for investors and stakeholders regarding company events and financial information.
Risk Assessment
Risk Level: low — The filing appears to be a standard disclosure of financial statements and exhibits, not indicating any immediate or significant risks.
Key Numbers
- 2024-11-20 — Date of Report (Earliest event reported)
- 001-33500 — Commission File Number (SEC Filing identifier)
Key Players & Entities
- Jazz Pharmaceuticals plc (company) — Registrant
- Ireland (location) — Jurisdiction of Incorporation
- Dublin (location) — Principal executive offices
FAQ
What specific financial statements or exhibits are being filed with this 8-K?
The provided excerpt states that the filing includes 'Financial Statements and Exhibits' but does not list the specific documents included.
What is the exact date of the earliest event reported in this 8-K?
The earliest event reported is dated November 20, 2024.
Where are Jazz Pharmaceuticals plc's principal executive offices located?
The principal executive offices are located at Fifth Floor, Waterloo Exchange, Waterloo Road, Dublin 4, Ireland.
What is the IRS Employer Identification Number for Jazz Pharmaceuticals plc?
The IRS Employer Identification Number is 98-1032470.
Under which section of the Securities Exchange Act of 1934 is this report filed?
This report is filed pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934.
Filing Stats: 495 words · 2 min read · ~2 pages · Grade level 12.1 · Accepted 2024-11-21 06:06:02
Key Financial Figures
- $0.0001 — istered Ordinary shares, nominal value $0.0001 per share JAZZ The Nasdaq Stock Mar
Filing Documents
- d832756d8k.htm (8-K) — 24KB
- d832756dex991.htm (EX-99.1) — 38KB
- g832756dsp4.jpg (GRAPHIC) — 10KB
- g832756g1121070300398.jpg (GRAPHIC) — 7KB
- 0001193125-24-262940.txt ( ) — 219KB
- jazz-20241120.xsd (EX-101.SCH) — 2KB
- jazz-20241120_lab.xml (EX-101.LAB) — 18KB
- jazz-20241120_pre.xml (EX-101.PRE) — 11KB
- d832756d8k_htm.xml (XML) — 4KB
Financial Statements and Exhibits
Financial Statements and Exhibits. (d) Exhibits Exhibit Number Description 99.1 Press Release dated November 20, 2024. 104 104 Cover Page Interactive Data File (embedded within the Inline XBRL document)
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. JAZZ PHARMACEUTICALS PUBLIC LIMITED COMPANY By: /s/Neena Patil Name: Neena Patil Title: Executive Vice President and Chief Legal Officer Date: November 21, 2024